Technology News and Research

RSS

Study shows that DBT increases cancer detection, reduces recall rates

Researchers have found that digital breast tomosynthesis (DBT) led to reduced recall rates and an increase in cancer detection in a large breast cancer screening program.

3 Dec 2013

White paper discusses the effects of particle shape and size on the properties of medical materials

Ceram, the international materials technology company, has published a new white paper for the medical devices industry, ‘The Effects of Particle Size Distribution on the Properties of Medical Materials’.

3 Dec 2013

Digital breast tomosynthesis reduces recall rates and increases cancer detection

Researchers have found that digital breast tomosynthesis (DBT) led to reduced recall rates and an increase in cancer detection in a large breast cancer screening program. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA).

3 Dec 2013

New genetics promises to change faulty genes of future generations by using "designer sperm”

Bethesda, MD-Get ready: The "new genetics" promises to change faulty genes of future generations by introducing new, functioning genes using "designer sperm." A new research report appearing online in The FASEB Journal, shows that introducing new genetic material via a viral vector into the sperm of mice leads to the presence and activity of those genes in the resulting embryos.

3 Dec 2013

Siemens Healthcare to introduce new angiography system at RSNA 2013

At the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America, December 1-6 in Chicago, Siemens Healthcare (booth #1934, South Building/Lakeside Center at McCormick Place, Hall A) will introduce a new angiography system optimized for broad clinical utilization.

3 Dec 2013

3D mammography identifies 22% more breast cancers than traditional mammography

Compared to traditional mammography, 3D mammography—known as digital breast tomosynthesis—found 22 percent more breast cancers and led to fewer call backs in a large screening study at the Hospital of the University of Pennsylvania, researchers reported today at the annual meeting of the Radiological Society of North America.

3 Dec 2013

VRC scientists receive $2.2M grant to develop new resin composite dental fillings

The American Dental Association and the ADA Foundation today announced that the foundation's Anthony Volpe Research Center (VRC) received a five-year, $2.2 million grant from the National Institute of Dental and Craniofacial Research (NIDCR) to develop new resin composite dental fillings.

3 Dec 2013

Insurers worry about back end repairs to HealthCare.gov

The system that is supposed to deliver consumers' information to insurers still needs to be repaired -- with only 30 days to go before coverage is supposed to begin for many people. Meanwhile, Bloomberg News reports that insurers will initially estimate what they are owed by the government rather than have the government calculate the bill due to another software problem.

3 Dec 2013

Gore receives Shonin approval from Japan to market GORE C3 Delivery System

W. L. Gore & Associates, Inc. has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare to market the GORE EXCLUDER AAA Endoprosthesis featuring C3 Delivery System as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm.

3 Dec 2013

Virginia Mason first to use non-invasive FibroScan technology to evaluate liver diseases

Virginia Mason today becomes the first in the Pacific Northwest to use non-invasive FibroScan technology to evaluate disease stage in patients diagnosed with liver ailments.

3 Dec 2013

Investigators use new technique to identify pathogens faster, directly from clinical samples

A team of Danish investigators has shown how to identify pathogens faster, directly from clinical samples. The research, published online ahead of print in the Journal of Clinical Microbiology appears in the journal's January 2014 issue.

2 Dec 2013

Xagenic announces closing of $20 million Series B financing

Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, today announced the close of a Series B financing totaling $20 million. The round was led by new investor Domain Associates, LLC, which was joined by existing investors including CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.

2 Dec 2013

First Edition: December 2, 2013

Today's early morning highlights from the major news organizations, including reports about healthcare.gov's status, the challenges that lie ahead and the concerns being expressed by consumers and insurers.

2 Dec 2013

Toshiba's M-Power interface simplifies MR scans and helps improve patient care

Healthcare providers are able to do more with less and improve patient care thanks to Toshiba America Medical Systems, Inc.'s enhanced M-Power user interface. Toshiba's M-Power interface simplifies MR scans by automatically guiding clinicians to complete exams accurately and efficiently. Combined with the large bore, quiet MR technology and advanced non-contrast techniques of Toshiba's MR systems, clinicians can offer an overall more comfortable and safer exam.

2 Dec 2013

JHL Biotech installs GE Healthcare's FlexFactory biomanufacturing platform at Hsinchu plant in Taiwan

GE Healthcare Life Sciences and JHL Biotech today announced that GE Healthcare has completed installation of its FlexFactory biomanufacturing platform at JHL Biotech's Research Center and manufacturing plant in Hsinchu, Taiwan.

2 Dec 2013

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.

2 Dec 2013

New biomarkers to improve diagnostics of prostate cancer

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.

2 Dec 2013

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.

2 Dec 2013

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing, today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

2 Dec 2013

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

To be published online Monday, Dec. 2, a special issue of the Journal of the American College of Radiology addresses imaging-based screening and radiology's increasing role in preventive medicine. Topics covered include breast density legislation, digital breast tomosynthesis (or 3-D mammography), lung cancer screening and computed tomography colonography reimbursement.

2 Dec 2013

Technology News and Research

Study shows that DBT increases cancer detection, reduces recall rates

White paper discusses the effects of particle shape and size on the properties of medical materials

Digital breast tomosynthesis reduces recall rates and increases cancer detection

New genetics promises to change faulty genes of future generations by using "designer sperm”

Siemens Healthcare to introduce new angiography system at RSNA 2013

3D mammography identifies 22% more breast cancers than traditional mammography

VRC scientists receive $2.2M grant to develop new resin composite dental fillings

Insurers worry about back end repairs to HealthCare.gov

Gore receives Shonin approval from Japan to market GORE C3 Delivery System

Virginia Mason first to use non-invasive FibroScan technology to evaluate liver diseases

Investigators use new technique to identify pathogens faster, directly from clinical samples

Xagenic announces closing of $20 million Series B financing

First Edition: December 2, 2013

Toshiba's M-Power interface simplifies MR scans and helps improve patient care

JHL Biotech installs GE Healthcare's FlexFactory biomanufacturing platform at Hsinchu plant in Taiwan

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

New biomarkers to improve diagnostics of prostate cancer

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News